Patents

Topical Formulation for Raynaud’s Phenomenon

This patented composition contains nitroglycerin, oleic acid, alpha hydroxy acid and an emollient.

Raynaud's syndrome phenomena in adult hand.

US Patent No.12,070,440 B2 (Edward T. Kisak, John M. Newsam, R. Dominic King-Smith); Permeautus, Inc., Del Mar, CA, has patented a pharmaceutically-acceptable topical composition for treating conditions such as Raynaud’s phenomenon in which peripheral blood flow in a subject is compromised.

The composition is comprised at least 4% weight by weight of nitroglycerin, at least 8% oleic acid, 1.425-1.575% of an emollient comprising a fatty acid ester of an alpha hydroxy acid, 2.85 -3.15% of hydroxypropyl cellulose, and at least 63% by weight of propylene glycol. The  composition is free of both water and hydrocarbon. The nitroglycerin is homogeneously distributed throughout the composition.

Raynaud phenomenon is a common condition, occurring in 3-5% of adults worldwide. It is more common in females than males.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters